Cresco to enter FL medical marijuana market via $120M VidaCann purchase
Cresco Labs, a Chicago-based vertically integrated cannabis company, agreed to acquire Florida medical marijuana provider VidaCann in a…
News March 18
Latest In: Stocks
Harvest Health sets cannabis industry standard with $850 million acquisition of multistate operator Verano
Arizona-based Harvest Health & Recreation reached a binding agreement to acquire Verano Holdings of Chicago for $850 million,…
News March 11
Marijuana firm Cronos closes CA$2.4 billion investment from tobacco giant Altria
Altria Group's record-breaking investment of 2.4 billion Canadian dollars ($1.8 billion) in Ontario-based cannabis producer Cronos Group closed…
News March 8
‘Forefront of consolidation’: Shareholders OK marijuana merger of Emblem, Aleafia
Shareholders of Ontario-based cannabis producer Emblem approved a 173 million Canadian dollar ($128 million) buyout from vertically integrated…
News March 8
Cannabis data firm Headset to partner with global analytics company Nielsen
Global measurement and data analytics company Nielsen has formed an alliance with Seattle-based cannabis analytics firm Headset to…
News March 6
Denver cannabis firm with franchise model to list on Canadian stock exchange
A Denver cannabis company that plans to help franchisees set up marijuana retail businesses is set to go…
News March 6
Cannabis firm MedMen distances itself from stock promoter after OTC scrutiny
California-based marijuana retailer MedMen disclosed that a content production firm it paid wound up promoting the company’s stock…
News March 5
Adult-use cannabis bills move ahead in three states and other top stories from the week ending March 1 (SLIDESHOW)
New Hampshire, New Mexico and Vermont advance recreational marijuana bills, California's MJ licensing bottleneck could trigger the supply…
News March 1
Marijuana firm MedMen’s fiscal Q2 sales grow, losses shrink from previous quarter
Los Angeles-based MedMen reported revenue of $29.9 million and a net loss of $64.6 million for its fiscal…
News February 27
GW Pharma denies supply issues with marijuana-based drug Epidiolex after stock falls
GW Pharmaceuticals, the British maker of epileptic seizure-control medication Epidiolex, said it was not aware of any supply…
News February 21
Latest Sponsored
